Literature DB >> 26622871

CXCL1 expression is correlated with Snail expression and affects the prognosis of patients with gastric cancer.

Zhen Xiang1, DA-Ping Jiang2, Guang-Gai Xia1, Zhe-Wei Wei1, Wei Chen1, Yulong He1, Chang-Hua Zhang1.   

Abstract

Gastric cancer (GC) continues to result in a poor survival rate and prognostic biomarkers for the disease are lacking. Chemokine (C-X-C motif) ligand (CXCL1) expression plays a critical role in tumor metastasis, and Snail promotes epithelial-mesenchymal transition (EMT) to promote metastasis. Therefore, the present study aimed to investigate the correlation between CXCL1 and Snail expression and the effect of CXCL1 expression on the survival of patients with GC. CXCL1 and Snail expression in paraffin-embedded tissue sections from 127 patients with GC were each assessed by immunohistochemistry. Cox regression and Kaplan-Meier analyses were performed to evaluate the prognostic significance of CXCL1 and Snail. Evaluation of the association between CXCL1 and Snail expression and clinical characteristics was based on the χ2 test. Spearman's rank correlation coefficient and Fisher's exact test were used to explore the association between CXCL1 and Snail expression in GC tissues. CXCL1 was found to be significantly associated with tumor invasion (P=0.003), tumor-node-metastasis (TNM) staging (P=0.001), tumor size (P=0.013) and lymph node metastasis (P=0.022) in GC. Snail overexpression was also significantly associated with tumor invasion (P=0.001), TNM staging (P=0.005), tumor size (P=0.026), lymph node metastases (P=0.014) and perineural invasion (P=0.009). CXCL1 and Snail expression were independent factors for a worse overall survival rate, as determined by multivariate analysis (P=0.011 and P=0.018; respectively). The combined expression of CXCL1 and Snail resulted in a worse prognosis compared with the other three groups (P=0.005). Furthermore, there was a significantly positive correlation between CXCL1 and Snail expression in GC (r=0.431; P<0.001). The expression of CXCL1 is significantly associated with Snail expression and may be used as a predictive co-biomarker for patient prognosis and tumor aggressiveness in GC. CXCL1 may promote GC metastasis by regulating EMT.

Entities:  

Keywords:  CXCL1; Snail; gastric cancer; overall survival; prognosis

Year:  2015        PMID: 26622871      PMCID: PMC4579984          DOI: 10.3892/ol.2015.3614

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  25 in total

1.  G9a interacts with Snail and is critical for Snail-mediated E-cadherin repression in human breast cancer.

Authors:  Chenfang Dong; Yadi Wu; Jun Yao; Yifan Wang; Yinhua Yu; Piotr G Rychahou; B Mark Evers; Binhua P Zhou
Journal:  J Clin Invest       Date:  2012-03-12       Impact factor: 14.808

Review 2.  Status and prognosis of lymph node metastasis in patients with cardia cancer - a systematic review.

Authors:  Cecilie Okholm; Lars Bo Svendsen; Michael P Achiam
Journal:  Surg Oncol       Date:  2014-06-11       Impact factor: 3.279

3.  Snail is an independent prognostic predictor for progression and patient survival of gastric cancer.

Authors:  Hongyong He; Weidong Chen; Xuefei Wang; Cong Wang; Fenglin Liu; Zhenbin Shen; Jiejie Xu; Jianxin Gu; Yihong Sun
Journal:  Cancer Sci       Date:  2012-05-15       Impact factor: 6.716

4.  Growth regulated oncogene-alpha expression by murine squamous cell carcinoma promotes tumor growth, metastasis, leukocyte infiltration and angiogenesis by a host CXC receptor-2 dependent mechanism.

Authors:  E Loukinova; G Dong; I Enamorado-Ayalya; G R Thomas; Z Chen; H Schreiber; C Van Waes
Journal:  Oncogene       Date:  2000-07-20       Impact factor: 9.867

5.  Sonic hedgehog pathway promotes metastasis and lymphangiogenesis via activation of Akt, EMT, and MMP-9 pathway in gastric cancer.

Authors:  Young A Yoo; Myoung Hee Kang; Hyun Joo Lee; Baek-hui Kim; Jong Kuk Park; Hyun Koo Kim; Jun Suk Kim; Sang Cheul Oh
Journal:  Cancer Res       Date:  2011-10-05       Impact factor: 12.701

6.  Secreted CXCL1 is a potential mediator and marker of the tumor invasion of bladder cancer.

Authors:  Hiroaki Kawanishi; Yoshiyuki Matsui; Masaaki Ito; Jun Watanabe; Takeshi Takahashi; Koji Nishizawa; Hiroyuki Nishiyama; Toshiyuki Kamoto; Yoshiki Mikami; Yoshinori Tanaka; Giman Jung; Hideo Akiyama; Hitoshi Nobumasa; Parry Guilford; Anthony Reeve; Yasushi Okuno; Gozoh Tsujimoto; Eijiro Nakamura; Osamu Ogawa
Journal:  Clin Cancer Res       Date:  2008-05-01       Impact factor: 12.531

7.  A new immunohistochemical antibody for the assessment of estrogen receptor status on routine formalin-fixed tissue samples.

Authors:  H Goulding; S Pinder; P Cannon; D Pearson; R Nicholson; D Snead; J Bell; C W Elston; J F Robertson; R W Blamey
Journal:  Hum Pathol       Date:  1995-03       Impact factor: 3.466

8.  COX-2 regulates E-cadherin expression through the NF-κB/Snail signaling pathway in gastric cancer.

Authors:  Zhaofeng Chen; Min Liu; Xiaojun Liu; Shanshan Huang; Linlin Li; Bo Song; Hailong Li; Qian Ren; Zenan Hu; Yongning Zhou; Liang Qiao
Journal:  Int J Mol Med       Date:  2013-05-10       Impact factor: 4.101

9.  NF-kappa B genes have a major role in inflammatory breast cancer.

Authors:  Florence Lerebours; Sophie Vacher; Catherine Andrieu; Marc Espie; Michel Marty; Rosette Lidereau; Ivan Bieche
Journal:  BMC Cancer       Date:  2008-02-04       Impact factor: 4.430

10.  CXCR2-driven ovarian cancer progression involves upregulation of proinflammatory chemokines by potentiating NF-κB activation via EGFR-transactivated Akt signaling.

Authors:  Yuan-Lin Dong; Syeda M Kabir; Eun-Sook Lee; Deok-Soo Son
Journal:  PLoS One       Date:  2013-12-20       Impact factor: 3.240

View more
  10 in total

Review 1.  Onco-GPCR signaling and dysregulated expression of microRNAs in human cancer.

Authors:  Nijiro Nohata; Yusuke Goto; J Silvio Gutkind
Journal:  J Hum Genet       Date:  2016-10-13       Impact factor: 3.172

2.  Gastrokine 1 inhibits gastric cancer cell migration and invasion by downregulating RhoA expression.

Authors:  Jung Hwan Yoon; Won Suk Choi; Olga Kim; Byung Joon Choi; Suk Woo Nam; Jung Young Lee; Won Sang Park
Journal:  Gastric Cancer       Date:  2016-06-01       Impact factor: 7.370

3.  Prognostic and clinicopathological significance of CXCL1 in cancers: a systematic review and meta-analysis.

Authors:  Zulei Zhang; Yuting Chen; Yaofei Jiang; Yan Luo; Hao Zhang; Yakun Zhan
Journal:  Cancer Biol Ther       Date:  2019-08-06       Impact factor: 4.742

4.  Elevated expression of growth-regulated oncogene-alpha in tumor and stromal cells predicts unfavorable prognosis in pancreatic cancer.

Authors:  Shuijin Lian; Xiaolu Zhai; Xudong Wang; Huijun Zhu; Shu Zhang; Wei Wang; Zhiwei Wang; Jianfei Huang
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889

5.  A novel gene expression-based prognostic scoring system to predict survival in gastric cancer.

Authors:  Pin Wang; Yunshan Wang; Bo Hang; Xiaoping Zou; Jian-Hua Mao
Journal:  Oncotarget       Date:  2016-08-23

6.  Chemokine (C-X-C motif) ligand 1 is associated with tumor progression and poor prognosis in patients with colorectal cancer.

Authors:  Changhua Zhuo; Xianyi Wu; Jing Li; Dan Hu; Jinliang Jian; Changjiang Chen; Xiongwei Zheng; Chunkang Yang
Journal:  Biosci Rep       Date:  2018-07-02       Impact factor: 3.840

7.  CXCL1 stimulates migration and invasion in ER‑negative breast cancer cells via activation of the ERK/MMP2/9 signaling axis.

Authors:  Chengcheng Yang; Haochen Yu; Rui Chen; Kai Tao; Lei Jian; Meixi Peng; Xiaotian Li; Manran Liu; Shengchun Liu
Journal:  Int J Oncol       Date:  2019-07-15       Impact factor: 5.650

8.  E-cadherin and Snail Immunoexpression in Colorectal Adenocarcinomas.

Authors:  A M Al Khatib; A E Stepan; C Margaritescu; C Simionescu; R N Ciurea
Journal:  Curr Health Sci J       Date:  2019-06-30

9.  An inter-correlation among chemokine (C-X-C motif) ligand (CXCL) 1, CXCL2 and CXCL8, and their diversified potential as biomarkers for tumor features and survival profiles in non-small cell lung cancer patients.

Authors:  Linping Gu; Yaxian Yao; Zhiwei Chen
Journal:  Transl Cancer Res       Date:  2021-02       Impact factor: 1.241

10.  Novel diagnostic and prognostic biomarkers of colorectal cancer: Capable to overcome the heterogeneity-specific barrier and valid for global applications.

Authors:  Yasir Hameed; Muhammad Usman; Shufang Liang; Samina Ejaz
Journal:  PLoS One       Date:  2021-09-02       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.